These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 884687)

  • 21. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R; Khokhar AR
    Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
    Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP
    J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and anti-tumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles.
    Khokhar AR; Al-Baker S; Perez-Soler R
    Anticancer Drug Des; 1988 Dec; 3(3):177-84. PubMed ID: 3207465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 26. Liposoluble platinum(II) complexes with antitumor activity.
    Maeda M; Uchida NA; Sasaki T
    Jpn J Cancer Res; 1986 Jun; 77(6):523-5. PubMed ID: 3015851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
    Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
    Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum-amine compounds: importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells.
    Macquet JP; Butour JL
    J Natl Cancer Inst; 1983 May; 70(5):899-905. PubMed ID: 6573534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for development of platinum analogs.
    Burchenal JH; Kalaher K; Dew K; Lokys L
    Cancer Treat Rep; 1979; 63(9-10):1493-8. PubMed ID: 498148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.
    Prestayko AW; Bradner WT; Huftalen JB; Rose WC; Schurig JE; Cleare MJ; Hydes PC; Crooke ST
    Cancer Treat Rep; 1979; 63(9-10):1503-8. PubMed ID: 498150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
    Eastman A; Illenye S
    Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Lopez-Berestein G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
    Waud WR
    Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Micetich K; Zwelling LA; Kohn KW
    Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic activity of platinum (II) complexes with tri-n-butylphosphine. Crystal structure of the dinuclear hydrazine-bridged complex, cis,cis-[PtCl(PBu3n)2(mu-N2H4)PtCl(PBu3n) 2] (ClO4)2.2CHCl3.
    Kozelka J; Segal E; Bois C
    J Inorg Biochem; 1992 Aug; 47(2):67-80. PubMed ID: 1431874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.